The UPSTREAM Management of Aortic Stenosis in the Future

ARCH Advanced Revascularization Symposium

M. Leon

First-in-man Use of Electrosurgical SESAME (SEptal Scoring Along the…

University of Miami

C. Sanina

Valve Replacement for Pure Native Aortic Regurgitation from Alpha to…

Patrick Serruys

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

American College of Cardiology

D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy

Lp(a): The New Kid on the Block

Complex Coronary Cases

P. Taub

CAD and Aortic Stenosis: Just Treat the Valve (Most of the Time)

ARCH Advanced Revascularization Symposium

M. Chung

Assessment of Aortic Regurgitation in the Current Era

Houston Methodist DeBakey Heart and Vascular Center

W. Zoghbi

Structural Heart Disease in Pregnant Women: Risk Stratification and …

The North American Thrombosis Forum (NATF)

A. Valente

Right Mini Thoracotomy: Replacement of Hemi-Arch, Asc Ao & Aortic Ro…

Miami Valves 2022

J. Lamelas

Unusual Case of Aortic Insufficiency with Exertional Angina

Ramesh Veeragandham

Echo Assessment of Valvular Disease

Michigan Medicine

S. Kohnstamm

Bicuspid Aortic Valve Disease: Strategies in Young Patients Includin…

Penn Medicine Heart and Vascular Center

J. Bavaria

The Future of TAVR - Where Will We Be In 2030? My Crystal Ball

University of Miami

E. Grube

Latest Update on Valvular Heart Disease: Strides Made, Looking to th…

New York Transcatheter Valves 2022

R. Bonow

Valvular Heart Disease and Aortic Stenosis Management in 2020: What …

New York Transcatheter Valves 2019

R. Nishimura

Quantification of AS and AI Severity by Echo

Scripps Health

M. Picard

TAVR in Bicuspid Aortic Valve Diease - Where Are We Now?

University of Miami

N. Van Mieghem

TAVR: Guidelines for TAVR vs. SAVR, VIV and Antithrombotic Therapy. …

American Heart & Vascular Institute

R. Sharma

TAVR + CAD: Rationale & Update on COMPLETE TAVR Trial

New York Transcatheter Valves 2021

D. Wood